# NI-0801 in Allergic Contact Dermatitis

> **NCT01244607** · PHASE1 · COMPLETED · sponsor: **Light Chain Bioscience - Novimmune SA** · enrollment: 22 (actual)

## Conditions studied

- Allergic Contact Dermatitis

## Interventions

- **DRUG:** Placebo
- **DRUG:** NI-0801

## Key facts

- **NCT ID:** NCT01244607
- **Lead sponsor:** Light Chain Bioscience - Novimmune SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2010-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01244607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01244607, "NI-0801 in Allergic Contact Dermatitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01244607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*